Increasing prevalence of chronic diseases such as cancer will drive the Europe cell line development market. Cancer is one of the leading causes of morbidity and mortality in Europe. Extensive investment in R&D activities to reduce cancer burden in the region, will fuel need for cell line development for cancer treatment.
Pune, Maharashtra -- (SBWIRE) -- 11/09/2018 -- Graphical Research presents a most up-to-date report on "Europe Cell Line Development Market analysis based on Product, Source, Cell Line, Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024", estimated to exceed USD 2.1 billion by 2024.
Growing disease burden across the globe is the key factor that will drive cell line development market growth. Rising demand for vaccines and monoclonal antibodies in treatment of cancer, autoimmune diseases and anti-inflammatory disease will fuel demand for cell line cultures. Developments in biotechnology industry, increasing healthcare expenditure coupled with growing adoption of technologically advanced products should accelerate the cell line development industry growth.
Request for a sample of this research report - https://www.graphicalresearch.com/request/1066/sample
Technological advancements in cell line development products is another major contributor for cell line development business growth. Availability of automated screening methods, enriched medias, disposable equipment and improved expression systems for enhancing cell line development practices will foster market growth. However, stringent regulatory constraints may hamper the cell line development industry growth over the forecast timeframe.
Reagents and media product segment accounted for largest market share of 53.6% in 2017 and is projected to show robust growth throughout the analysis period. Reagents and media form major component of cell culture procedures. Increasing usage of reagents and media in drug discovery, tissue engineering, and other research applications will accelerate the segmental growth over the analysis period.
Browse key industry insights from this 2018 report Europe Cell Line Development Market in detail along with the table of contents at:
https://www.graphicalresearch.com/industry-insights/1066/europe-cell-line-development-market
Mammalian cell cultures segment was valued at USD 650.8 million in 2017 and is estimated to show similar growth during the forecast period. The growth is attributable to increasing adoption of mammalian cell cultures for production of complex biotherapeutic proteins. Mammalian cell cultures are widely used in vaccine production for treatment of mumps, rubella and other diseases. Increasing acceptance of mammalian cell source to produce monoclonal antibodies will further boost the segmental growth.
Recombinant cell line type segment is anticipated to grow at 12.5% CAGR during the forthcoming years. Advent of rDNA technology has drastically increased the demand for recombinant cell lines. Wide adoption of rDNA technology in production of enzymes, synthetic hormones, immunobiologics and other anti-cancer drugs will foster growth of recombinant cell line type segment. Increasing demand for monoclonal antibodies in improving quality of life in patients suffering from cancer, anti-inflammatory disorders and autoimmune diseases will positively impact the segmental growth.
Germany cell line development market will grow considerably during the forecast period owing to increasing disease burden in the region. Growing adoption of vaccines and monoclonal antibodies will foster cell line development industry growth. Increasing investments in R&D activities will fuel the demand for cell cultures thereby driving business growth. Developments in biotechnology industry will further augment Germany cell line development market growth.
Key industry players operating in Europe cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy. Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry.
Make an inquiry for purchasing this report @ https://www.graphicalresearch.com/request/1066/inquiry-before-buying
Segments We Cover:
Europe Cell Line Development Market Statistics, By Product
Reagents and media, Equipment, Accessories
Europe Cell Line Development Market Trends, By Source
Mammalian, Non-mammalian
Europe Cell Line Development Market Analysis, By Cell Line Type
Recombinant cell lines, Hybridomas, Continuous cell lines, Primary cell lines
Europe Cell Line Development Market, By Application
Bioproduction, Drug discovery, Toxicity testing, Tissue engineering, Research
The above information is provided for the following countries:
Germany, UK, Spain, Italy, Russia, France, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, Netherlands, Sweden
Related Reports:
1. North America Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2018 – 2024
https://www.graphicalresearch.com/industry-insights/1067/north-america-cell-line-development-market
2. Asia-Pacific Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Industry Analysis Report, Regional Outlook (Japan, China, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Application Potential, Competitive Market Share & Forecast, 2018 – 2024
https://www.graphicalresearch.com/industry-insights/1065/asia-pacific-cell-line-development-market
About Graphical Research
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.